AzTrials
AzTrials

Palliative Care NursingPERCEPALNCT02900573

Withdrawal of Artificial Nutrition at the End of Life (PERCEPAL)

An observational study of Palliative Care Nursing, run by Centre Hospitalier Régional Metz-Thionville at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Withdrawing artificial nutrition in palliative care is an issue that often leads to ethical dilemmas among health care providers, despite clinical guidelines. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Palliative Care Nursing
How many people
289 participants
Where
1 siteFrance
Study dates
May 2010to Aug 2010
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Senior nurses (which are not directly in contact with the patient but involved in team management), nurses (which perform patient care), and nurses' aides (which are involved in hygiene measures) working in the medicine, surgery, and palliative care departments of the regional hospital of Metz-Thionville.

Who may be able to join

  • nurses, and nurses' aides working in medicine, surgery, and palliative care departments of the regional hospital of Metz-Thionville

Who cannot join

  • Care providers working in pediatrics, gynecology and obstetrics, psychiatry, and emergency departments

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHR Metz-Thionville

    Metz, 57085

Other trials in France

About this study

Official title: Caregivers Confronted With the Withdrawal of Artificial Nutrition at the End of Life: Perception and Experienced Difficulties

Withdrawing artificial nutrition in palliative care is an issue that often leads to ethical dilemmas among health care providers, despite clinical guidelines.

Read the detailed description

The benefit of artificial nutrition in terminally ill patients has been a highly debated issue for the past 30 years, and abundant data are available regarding its effects on patients. Several clinical guidelines have specified the criteria to be considered before initiating artificial nutrition or hydration. If these guidelines appear consensual in theory, the situation is much less straightforward in practice. The attitude of physicians appeared very variable when it came to prescribing or withholding artificial nutrition or hydration, and the lack of training, among other parameters, seemingly encouraged health care professionals to prescribe artificial nutrition or hydration. Furthermore, the decision of the care provider is unconsciously complicated due to figurative representations associated with food regarding, among other aspects, the mother-child relationship, social cohesion, or religious beliefs.

These differences are more important since the opinion of physicians and nurses is the one that carries the most influence on the patients' decision when deciding to initiate artificial nutrition and because artificial nutrition and hydration are a common source of ethical dilemmas in health care teams. Furthermore, stopping artificial nutrition or hydration could be misconstrued as euthanasia.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Experience of health care providers confronted with the withdrawing of artificial nutrition at the end of life

    Cross-sectional survey questionnaire

    Measured: month 4

Secondary outcomes (1)
  1. Experienced difficulties

    Cross-sectional survey questionnaire

    Measured: month 4

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2016 (estimated)
  2. Study startMay 2010
  3. Primary completionAug 2010
  4. Study completionAug 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
289 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02900573
Sponsor's protocol ID
2010-01Obs-CHRMT
Acronym
PERCEPAL
Status last verified
Aug 2016
First submitted
26 Aug 2016
Last updated
14 Sep 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Palliative Care Nursing, run by Centre Hospitalier Régional Metz-Thionville at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Experience of health care providers confronted with the withdrawing of artificial nutrition at the end of life (time frame: month 4). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in